Descripción del proyecto
Monoclonal antibodies against COVID-19
Previous experience on SARS and MERS coronaviruses is proving instrumental for the rapid development of new diagnostic, prophylactic and therapeutic intervention strategies against COVID-19. The EU-funded MANCO project is building on technology generated during the ongoing IMI-funded ZAPI project on monoclonal antibodies against coronaviruses. The researchers of MANCO will identify specific monoclonal antibodies against the new coronavirus and validate them at the preclinical level. The idea is to advance one lead prophylactic and/or therapeutic monoclonal antibody into a Phase I clinical trial and make results available within two years of the start of the project.
Ámbito científico
- /ciencias médicas y de la salud/ciencias de la salud/enfermedad infecciosa/virus ARN/coronavirus
Programa(s)
Convocatoria de propuestas
H2020-SC1-PHE-CORONAVIRUS-2020
Consulte otros proyectos de esta convocatoria
Régimen de financiación
RIA - Research and Innovation actionCoordinador
3015 GD Rotterdam
Países Bajos
Participantes (7)
3013 AK Rotterdam
3584 CS Utrecht
30559 Hannover
28006 Madrid
69393 Lyon
3605 LT Maarssen
69003 Lyon